SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-23-122148
Filing Date
2023-11-30
Accepted
2023-11-29 21:57:42
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 tm2330784-1_424b5.htm 424B5 588076
2 GRAPHIC lg_xortxtherapeutics-4clr.jpg GRAPHIC 26212
  Complete submission text file 0001104659-23-122148.txt   625323
Mailing Address SUITE 2400 - 745 THURLOW STREET VANCOUVER A1 V6E 0C5
Business Address SUITE 2400 - 745 THURLOW STREET VANCOUVER A1 V6E 0C5 403-607-2621
XORTX Therapeutics Inc. (Filer) CIK: 0001729214 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-269429 | Film No.: 231453837
SIC: 2834 Pharmaceutical Preparations